Denali Therapeutics Inc.
DNLI· Nasdaq
Denali Therapeutics Inc.
- Last sale
- Oct 2, 2026 · -2.58%
- Market cap
- $3.20B
- 159.85M shares
- Filings
- 787
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $330,531,000 | reported | |
| FY 2022 | 2022-12-31 | $105,065,000 | reported | |
| FY 2021 | 2021-12-31 | $48,657,000 | reported | |
| FY 2020 | 2020-12-31 | $335,561,000 | reported | |
| FY 2019 | 2019-12-31 | $26,320,000 revised | reported | |
| FY 2018 | 2018-12-31 | $129,100,000 revised | reported | |
| FY 2017 | 2017-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported |
Denali Therapeutics Inc. · CIK 1714899 · Engraved from SEC EDGAR
